Literature DB >> 15302945

Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo.

Séverine Deforges1, Alexey Evlashev1, Magali Perret1, Mireille Sodoyer2, Stéphane Pouzol2, Jean-Yves Scoazec3, Bertrand Bonnaud2, Olivier Diaz1, Glaucia Paranhos-Baccalà2, Vincent Lotteau1, Patrice André1.   

Abstract

Previous work on hepatitis C virus (HCV) led to the discovery of a new form of virus particle associating virus and lipoprotein elements. These hybrid particles (LVP for lipo-viro-particles) are enriched in triglycerides and contain at least apolipoprotein B (apoB), HCV RNA and core protein. These findings suggest that LVP synthesis could occur in liver and intestine, the two main organs specialized in the production of apoB-containing lipoprotein. To identify the site of LVP production, the genetic diversity and phylogenetic relationship of HCV quasispecies from purified LVP, whole serum and liver biopsies from chronically infected patients were studied. HCV quasispecies from LVP and liver differed significantly, suggesting that LVP were not predominantly synthesized in the liver but might also originate in the intestine. The authors therefore searched for the presence of HCV in the small intestine. Paraffin-embedded intestinal biopsies from 10 chronically HCV-infected patients and from 12 HCV RNA-negative controls (10 anti-HCV antibody-negative and two anti-HCV antibody-positive patients) were tested for HCV protein expression. HCV NS3 and NS5A proteins were stained in small intestine epithelial cells in four of the 10 chronically infected patients, and not in controls. Cells expressing HCV proteins were apoB-producing enterocytes but not mucus-secreting cells. These data indicate that the small intestine can be infected by HCV, and identify this organ as a potential reservoir and replication site. This further emphasizes the interaction between lipoprotein metabolism and HCV, and offers new insights into hepatitis C infection and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302945      PMCID: PMC2099454          DOI: 10.1099/vir.0.80071-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  46 in total

Review 1.  Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins.

Authors:  Edward A Fisher; Henry N Ginsberg
Journal:  J Biol Chem       Date:  2002-03-21       Impact factor: 5.157

2.  Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma.

Authors:  F Maggi; C Fornai; M L Vatteroni; M Giorgi; A Morrica; M Pistello; G Cammarota; S Marchi; P Ciccorossi; A Bionda; M Bendinelli
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

3.  Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly.

Authors:  J Luchoomun; M M Hussain
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

4.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

5.  Statistical analysis and graphical display of multivariate data on the Macintosh.

Authors:  J Thioulouse
Journal:  Comput Appl Biosci       Date:  1989-10

6.  Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.

Authors:  R Thomssen; S Bonk; A Thiele
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

7.  Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome.

Authors:  Florence Komurian-Pradel; Magali Perret; Birgit Deiman; Mireille Sodoyer; Vincent Lotteau; Glaucia Paranhos-Baccalà; Patrice André
Journal:  J Virol Methods       Date:  2004-03-01       Impact factor: 2.014

8.  Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection.

Authors:  S M Wolinsky; B T Korber; A U Neumann; M Daniels; K J Kunstman; A J Whetsell; M R Furtado; Y Cao; D D Ho; J T Safrit
Journal:  Science       Date:  1996-04-26       Impact factor: 47.728

9.  Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Authors:  Jean Michel Petit; Muriel Benichou; Laurence Duvillard; Valerie Jooste; Jean Baptiste Bour; Anne Minello; Bruno Verges; Jean Marcel Brun; Philippe Gambert; Patrick Hillon
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

10.  HCV RNA-dependent RNA polymerase replicates in vitro the 3' terminal region of the minus-strand viral RNA more efficiently than the 3' terminal region of the plus RNA.

Authors:  S Reigadas; M Ventura; L Sarih-Cottin; M Castroviejo; S Litvak; T Astier-Gin
Journal:  Eur J Biochem       Date:  2001-11
View more
  24 in total

1.  Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

Authors:  Juan C Zapata; Marco Goicochea; Yuka Nadai; Lindsay M Eyzaguirre; Jean K Carr; Luke J Tallon; Lisa Sadzewicz; Garry Myers; Claire M Fraser; Qi Su; Mahmoud Djavani; Igor S Lukashevich; Maria S Salvato
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

2.  Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis.

Authors:  Helal F Hetta; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Ahmed Medhat; Mahmoud I Nassar; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  J Med Microbiol       Date:  2016-05-10       Impact factor: 2.472

Review 3.  Hepatitis C virus host cell entry.

Authors:  Alexander Ploss; Matthew J Evans
Journal:  Curr Opin Virol       Date:  2012-01-04       Impact factor: 7.090

4.  Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.

Authors:  Qiang Ding; Markus von Schaewen; Gabriela Hrebikova; Brigitte Heller; Lisa Sandmann; Mario Plaas; Alexander Ploss
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  The strange and critical intersection of hepatitis C and lipoprotein metabolism: "C-zing" the oil.

Authors:  Stephen Caldwell; Kyle L Hoehn; Young S Hahn
Journal:  Hepatology       Date:  2012-12-12       Impact factor: 17.425

6.  Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.

Authors:  Olivier Diaz; François Delers; Marianne Maynard; Sylvie Demignot; Fabien Zoulim; Jean Chambaz; Christian Trépo; Vincent Lotteau; Patrice André
Journal:  J Gen Virol       Date:  2006-10       Impact factor: 3.891

Review 7.  Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.

Authors:  Elham Shirvani-Dastgerdi; Robert E Schwartz; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2016-08-06       Impact factor: 7.090

Review 8.  Underlying pathophysiology of HCV infection in HIV-positive drug users.

Authors:  Anuradha Balasubramanian; Jerome E Groopman; Ramesh K Ganju
Journal:  J Addict Dis       Date:  2008

9.  Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a.

Authors:  Bo-Kyoung Jung; Hye-Ran Kim; Gyu-Nam Park; Guangxiang Luo; Kyung-Soo Chang
Journal:  J Microbiol       Date:  2016-05-27       Impact factor: 3.422

10.  Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.

Authors:  Vinca Icard; Olivier Diaz; Caroline Scholtes; Laure Perrin-Cocon; Christophe Ramière; Ralf Bartenschlager; Francois Penin; Vincent Lotteau; Patrice André
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.